Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2022 May 31;606(7914):E5. doi: 10.1038/s41586-022-04879-8

Author Correction: Fundamental immune–oncogenicity trade-offs define driver mutation fitness

David Hoyos 1,#, Roberta Zappasodi 2,3,4,5,✉,#, Isabell Schulze 2,4, Zachary Sethna 1,6,7, Kelvin César de Andrade 8, Dean F Bajorin 3,7, Chaitanya Bandlamudi 9,10, Margaret K Callahan 3,7, Samuel A Funt 3,7, Sine R Hadrup 11, Jeppe S Holm 11, Jonathan E Rosenberg 3,7, Sohrab P Shah 1,12, Ignacio Vázquez-García 1, Britta Weigelt 9, Michelle Wu 13, Dmitriy Zamarin 2,3,7, Laura F Campitelli 14, Edward J Osborne 14, Mark Klinger 14, Harlan S Robins 14, Payal P Khincha 8, Sharon A Savage 8, Vinod P Balachandran 3,4,6,7,15, Jedd D Wolchok 2,3,4,16, Matthew D Hellmann 3,4,17, Taha Merghoub 2,3,4,16,, Arnold J Levine 18, Marta Łuksza 19, Benjamin D Greenbaum 1,12,
PMCID: PMC9200628  PMID: 35641605

Correction to: Nature 10.1038/s41586-022-4696-z,published online 11 May 2022.

In the version of this article initially published, the surname of author Chaitanya Bandlamudi was misspelt as Bandlamundi. The error has been corrected in the HTML and PDF versions of the article

Contributor Information

Roberta Zappasodi, Email: roz4022@med.cornell.edu.

Taha Merghoub, Email: merghout@mskcc.org.

Benjamin D. Greenbaum, Email: greenbab@mskcc.org


Articles from Nature are provided here courtesy of Nature Publishing Group

RESOURCES